T. Rowe Price Associates’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2M | Buy |
20,340
+563
| +3% | +$55.4K | ﹤0.01% | 1635 |
|
|
2025
Q1 | $1.83M | Buy |
19,777
+1,481
| +8% | +$137K | ﹤0.01% | 1645 |
|
|
2024
Q4 | $1.66M | Buy |
18,296
+1,625
| +10% | +$148K | ﹤0.01% | 1723 |
|
|
2024
Q3 | $1.61M | Buy |
16,671
+256
| +2% | +$24.7K | ﹤0.01% | 1741 |
|
|
2024
Q2 | $1.51M | Sell |
16,415
-14,784
| -47% | -$1.36M | ﹤0.01% | 1699 |
|
|
2024
Q1 | $2.88M | Buy |
31,199
+255
| +0.8% | +$23.5K | ﹤0.01% | 1407 |
|
|
2023
Q4 | $2.94M | Sell |
30,944
-4,186
| -12% | -$398K | ﹤0.01% | 1379 |
|
|
2023
Q3 | $3.28M | Sell |
35,130
-193,051
| -85% | -$18M | ﹤0.01% | 1296 |
|
|
2023
Q2 | $20.9M | Sell |
228,181
-21,982
| -9% | -$2.01M | ﹤0.01% | 925 |
|
|
2023
Q1 | $18.4M | Sell |
250,163
-22,766
| -8% | -$1.67M | ﹤0.01% | 938 |
|
|
2022
Q4 | $22.8M | Sell |
272,929
-73,274
| -21% | -$6.12M | ﹤0.01% | 874 |
|
|
2022
Q3 | $33.5M | Sell |
346,203
-400,065
| -54% | -$38.7M | 0.01% | 757 |
|
|
2022
Q2 | $78.4M | Sell |
746,268
-168,412
| -18% | -$17.7M | 0.01% | 732 |
|
|
2022
Q1 | $158M | Sell |
914,680
-327,766
| -26% | -$56.5M | 0.02% | 601 |
|
|
2021
Q4 | $201M | Sell |
1,242,446
-29,940
| -2% | -$4.85M | 0.02% | 554 |
|
|
2021
Q3 | $190M | Sell |
1,272,386
-211,615
| -14% | -$31.6M | 0.02% | 562 |
|
|
2021
Q2 | $363M | Sell |
1,484,001
-59,893
| -4% | -$14.7M | 0.03% | 410 |
|
|
2021
Q1 | $409M | Sell |
1,543,894
-16,563
| -1% | -$4.39M | 0.04% | 373 |
|
|
2020
Q4 | $458M | Buy |
1,560,457
+52,343
| +3% | +$15.4M | 0.05% | 339 |
|
|
2020
Q3 | $357M | Sell |
1,508,114
-11,748
| -0.8% | -$2.78M | 0.04% | 358 |
|
|
2020
Q2 | $302M | Sell |
1,519,862
-33,891
| -2% | -$6.73M | 0.04% | 382 |
|
|
2020
Q1 | $285M | Sell |
1,553,753
-20,869
| -1% | -$3.83M | 0.05% | 345 |
|
|
2019
Q4 | $263M | Buy |
1,574,622
+83,024
| +6% | +$13.9M | 0.03% | 425 |
|
|
2019
Q3 | $195M | Buy |
1,491,598
+142,193
| +11% | +$18.6M | 0.03% | 453 |
|
|
2019
Q2 | $164M | Buy |
1,349,405
+999,892
| +286% | +$121M | 0.02% | 512 |
|
|
2019
Q1 | $43.1M | Buy |
349,513
+55,223
| +19% | +$6.81M | 0.01% | 927 |
|
|
2018
Q4 | $34.5M | Buy |
294,290
+98,118
| +50% | +$11.5M | 0.01% | 959 |
|
|
2018
Q3 | $24.5M | Buy |
196,172
+184,506
| +1,582% | +$23.1M | ﹤0.01% | 1159 |
|
|
2018
Q2 | $997K | Buy |
11,666
+40
| +0.3% | +$3.42K | ﹤0.01% | 1840 |
|
|
2018
Q1 | $702K | Sell |
11,626
-2,244
| -16% | -$135K | ﹤0.01% | 1941 |
|
|
2017
Q4 | $731K | Sell |
13,870
-10
| -0.1% | -$527 | ﹤0.01% | 1909 |
|
|
2017
Q3 | $777K | Buy |
13,880
+1,500
| +12% | +$84K | ﹤0.01% | 1879 |
|
|
2017
Q2 | $778K | Hold |
12,380
| – | – | ﹤0.01% | 1878 |
|
|
2017
Q1 | $632K | Sell |
12,380
-3,000
| -20% | -$153K | ﹤0.01% | 1973 |
|
|
2016
Q4 | $656K | Buy |
+15,380
| New | +$656K | ﹤0.01% | 1939 |
|